|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil and Low Dose Leucovorin in Patients with Advanced Colorectal Cancer
Yoon Mi Shin, Hae Suk Han, Seong Woo Lim, Byung Chul Kim, Kyung Suck Cheoi, Young Ook Eum, Seung Taek Kim, Ki Hyeong Lee
Cancer Res Treat.
2005;37(5):284-289. Published online October 31, 2005 DOI:
https://doi.org/10.4143/crt.2005.37.5.284
Cited By 3
Neadjuvant Chemotherapy with 5-Fluorouracil Infusion and Cisplatin Followed by Radiotherapy for Locally Advanced Head and Neck Cancer
Yung Jue Bang, Sung Soo Yoon, Keun Chil Park, Jae Hoon Lee, Seung Taek Kim, Noe Kyeong Kim, Charn Il Park, Kwang Hyun Kim, Yang Gi Min
J Korean Cancer Assoc.
1988;20(1):82-90.
5-FU Infusion and Cisplatin in Patients with Disseminated or Recurrent Head and Neck Cancer
Jae Hoon Lee, Sung Soo Yoon, Keun Chil Park, Seung Taek Kim, Yung Jue Bang, Noe Kyeong Kim, Kwang Hyun Kim, Yang Gi Min, Charn Il Park
J Korean Cancer Assoc.
1988;20(1):67-73.
5-Fluorouracil Continuous Infusion and Mitomycin-C ( FM ) Combination Chemotherapy for Metastatic or Recurrent Colorectal Cancer
Keun Chil Park, Sung Soo Yoon, Jae Hoon Lee, Seung Taek Kim, Yung Jue Bang, Noe Kyeong Kim, Jae Gahb Park, Kuhn Uk Lee, Sung Kuk Hong, Kuk Jin Choe, Soo Tae Kim, Sung Whan Ha, Charn Il Park
J Korean Cancer Assoc.
1987;19(2):101-107.
Dimethyl Triazeno Imidazole Carboxamide ( DTIC ) Therapy in Metastatic Malignant Melanoma
Keun Chil Park, Keun Chil Park, Jae Hoon Lee, Seung Taek Kim, Yung Jue Bang, Noe Kyeong Kim
J Korean Cancer Assoc.
1987;19(2):95-101.
1
Journal Impact Factor 4.6